eXoZymes, Inc. (EXOZ)
NASDAQ: EXOZ · Real-Time Price · USD
8.85
-0.05 (-0.56%)
At close: Feb 27, 2026, 4:00 PM EST
8.51
-0.34 (-3.84%)
After-hours: Feb 27, 2026, 4:00 PM EST
eXoZymes Employees
eXoZymes had 31 employees as of December 31, 2024. The number of employees increased by 2 or 6.90% compared to the previous year.
Employees
31
Change (1Y)
2
Growth (1Y)
6.90%
Revenue / Employee
n/a
Profits / Employee
-$269,022
Market Cap
74.34M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 31 | 2 | 6.90% |
| Dec 31, 2023 | 29 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Pliant Therapeutics | 171 |
| Adicet Bio | 152 |
| Seres Therapeutics | 103 |
| Fractyl Health | 101 |
| XBiotech | 88 |
| PolyPid | 60 |
| Entera Bio | 22 |
| Annovis Bio | 15 |
EXOZ News
- 17 days ago - With Refreshed Brand eXoZymes Sharpens Pharmaceutical Focus to Drive Platform Leverage and Long-Term Value Creation - Accesswire
- 4 weeks ago - eXoZymes Advancing Commercial Readiness With Profound Production Metrics on Initial NCT Pilot Run - Accesswire
- 2 months ago - eXoZymes Achieves 100× Scale-up of NCT Production Using Exozymes, Demonstrating Near-perfect Feedstock Conversion - Accesswire
- 3 months ago - eXoZymes Provides Third Quarter 2025 Update at 5PM EST Today - Accesswire
- 3 months ago - eXoZymes Announces Cell-Free Biomanufacturing Pioneer, Tyler Korman, As CSO & Amy Lunzer as Chief of Staff - Accesswire
- 3 months ago - eXoZymes to Host Third Quarter 2025 Update on Thursday November 13, 2025, at 5PM EST - Accesswire
- 4 months ago - CEO of eXoZymes on 'AI in Life Sciences' panel at the Beryl Elites' Investment Conference - Accesswire
- 4 months ago - CEO of eXoZymes to Present at Spartan Capital Securities' Second Annual Investor Conference - Accesswire